News

In exchange for a one-time, upfront payment of $5.0 million, Infinity receives an option to terminate its obligation to pay Millennium future royalties related to the sale of

The acquisition will include the Intellectual Properties ("IP"), assets and talents of this cancer-therapy-focused developmental stage company. The IP is comprised of T Cells Receptor ("TCR") clonality analysis

The deal provides toxicity and efficacy studies of cannabinoid formulations carried out in animal models for neurobehavioral diseases including sleep disorders. The company said that the first formulation

In the trial, dosing of the first infant will be carried out within the next few weeks, when Isis will receive an $18m milestone payment from its development

Striverdi Respimat, a long-acting beta agonist (LABA) delivered via a propellant-free inhaler, is not indicated for the treatment of acute deteriorations of COPD and also for asthma. The

Additionally, ANI acquired approved ANDAs from Shire for the currently non-marketed products vancomycin hydrochloride injectable 500mg, 1gm and 10gm and vancomycin hydrochloride oral solution 250mg and 500mg. In

A rare, debilitating neurologic disorder, MG is caused by uncontrolled complement activation due to antibodies directed at the neuromuscular junction, ultimately leading to profound and debilitating weakness of

The double-blinded, placebo controlled trial is evaluating the use of the monoclonal antibody therapy designed to block chronic inflammation associated with malignant tumor growth. According to the company,

The approval of this indication is now consistent with that of the rest of the world, where alglucosidase alfa manufactured at the 4000L is the only scale available.